Charles River Laboratories International, Inc. (CRL)
NYSE: CRL · Real-Time Price · USD
295.19
+3.74 (1.28%)
At close: Aug 21, 2026, 4:00 PM EDT
295.15
-0.04 (-0.01%)
After-hours: Aug 21, 2026, 7:38 PM EDT

CRL Stock Forecast

Stock Price Forecast

According to 16 analysts polled by S&P Global, CRL stock has a consensus rating of "Buy" and an average price target of $281. The average 1-year stock price forecast is 4.81% lower than the current stock price, while the lowest is $145 (-50.88%) and the highest is $318 (+7.73%).

Price Target: $281 (-4.81%)
Analyst Consensus: Buy

Price Target

Chart
TargetLowAverageMedianHigh
Price$145$281$300$318
Change-50.88%-4.81%+1.63%+7.73%

Analyst Ratings

The average analyst rating for CRL stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.

Recommendation Trends

Chart
RatingMar '26Apr '26May '26Jun '26Jul '26Aug '26
Strong Buy1010101099
Buy123434
Hold643232
Sell011000
Strong Sell000111
Total171717171616

Latest Forecasts

AnalystFirmRatingRatingActionPrice TargetUpsideDate
Mizuho Securities
Mizuho Securities
Hold
Maintains
$230$264
HoldMaintains$230$264-10.57%Aug 10, 2026
TD Cowen
TD Cowen
Buy
Reiterates
$235$300
BuyReiterates$235$300+1.63%Aug 10, 2026
Morgan Stanley
Morgan Stanley
Buy
Reiterates
$260$300
BuyReiterates$260$300+1.63%Aug 7, 2026
Robert W. Baird
Robert W. Baird
Buy
Maintains
$255$291
BuyMaintains$255$291-1.42%Aug 6, 2026
Deutsche Bank
Deutsche Bank
Buy
Maintains
$260$300
BuyMaintains$260$300+1.63%Aug 6, 2026
More Analyst Ratings

Financial Forecast

Revenue This Year
3.91B
from 4.02B
Decreased by -2.60%
Revenue Next Year
4.00B
from 3.91B
Increased by 2.29%
EPS This Year
11.32
from 10.28
Increased by 10.10%
EPS Next Year
12.69
from 11.32
Increased by 12.08%
Fiscal YearFY 2021FY 2022FY 2023FY 2024FY 2025FY 2026
Period EndingDec 25, 2021Dec 31, 2022Dec 30, 2023Dec 28, 2024Dec 27, 2025Dec 31, 2026
Revenue
3.54B3.98B4.13B4.05B4.02B3.91B
Revenue Growth
21.08%12.31%3.86%-1.92%-0.85%-2.60%
Gross Profit
1.34B1.47B1.53B1.41B1.40B1.35B
Gross Margin
37.78%36.91%37.03%34.76%34.98%34.56%
Operating Income
634.39M665.51M648.89M545.86M497.76M820.99M
Net Income
390.98M486.23M474.62M22.20M-144.34M162.35M
EPS
----10.2811.32
EPS Growth
-----0.39%10.10%
Forward PE
33.7219.6622.7418.5319.3226.08
Free Cash Flow
629.60M303.66M214.21M489.63M572.38M315.60M
No. Analysts
-----12
EPS and Forward PE are based on non-GAAP adjusted numbers.

Revenue Forecast

Revenue202620272028
High4.0B
Avg3.9B
Low3.9B

Revenue Growth

Revenue Growth202620272028
High
-1.4%
Avg
-2.6%
Low
-2.9%

EPS Forecast

EPS202620272028
High11.46
Avg11.32
Low11.02

EPS Growth

EPS Growth202620272028
High
11.4%
Avg
10.1%
Low
7.2%